| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17,235 |
8,059 |
$1.35M |
| 36415 |
Collection of venous blood by venipuncture |
36,606 |
23,143 |
$484K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,037 |
4,063 |
$78K |
| 80053 |
Comprehensive metabolic panel |
5,660 |
5,295 |
$70K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,919 |
1,858 |
$43K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,430 |
10,996 |
$43K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,655 |
4,510 |
$34K |
| 80061 |
Lipid panel |
2,770 |
2,718 |
$29K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,736 |
2,543 |
$26K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
25,707 |
15,961 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,192 |
4,205 |
$22K |
| 81001 |
|
2,224 |
2,074 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,638 |
3,518 |
$18K |
| 85027 |
|
6,101 |
5,558 |
$9K |
| 85610 |
|
5,835 |
2,281 |
$9K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
8,664 |
6,609 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
94 |
85 |
$5K |
| 87186 |
|
1,144 |
979 |
$5K |
| 87650 |
|
460 |
423 |
$5K |
| 82607 |
|
767 |
748 |
$5K |
| 83735 |
|
796 |
665 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
39 |
19 |
$3K |
| 83655 |
|
155 |
155 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
93 |
90 |
$2K |
| 85018 |
|
1,140 |
923 |
$1K |
| 82043 |
|
86 |
85 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
78 |
76 |
$1K |
| 84439 |
|
126 |
123 |
$652.63 |
| 86780 |
|
65 |
65 |
$549.62 |
| 87088 |
|
103 |
87 |
$538.27 |
| 82570 |
|
91 |
90 |
$410.13 |
| 82248 |
|
91 |
86 |
$390.62 |
| 82565 |
|
181 |
160 |
$342.67 |
| 87081 |
|
25 |
24 |
$235.92 |
| 82728 |
|
54 |
51 |
$230.34 |
| 86140 |
|
54 |
41 |
$221.30 |
| 83540 |
|
96 |
89 |
$209.85 |
| 84460 |
|
115 |
111 |
$124.13 |
| 86803 |
|
12 |
12 |
$109.63 |
| 84132 |
|
47 |
38 |
$95.60 |
| 82040 |
|
87 |
83 |
$90.60 |
| 80164 |
|
13 |
12 |
$68.60 |
| 84466 |
|
13 |
12 |
$39.10 |
| 81003 |
|
16 |
15 |
$30.88 |
| 83721 |
|
17 |
16 |
$18.53 |
| 83880 |
|
14 |
14 |
$4.82 |
| 86592 |
|
12 |
12 |
$0.00 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
37 |
37 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
74 |
37 |
$0.00 |